White matter microstructure fingerprint of cerebral small vessel disease
Brain · 06.06.2026
DOI: 10.1093/brain/awag200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 06.06.2026. Verfasst von Aurélie Bussy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Imaging Neuroscience of Ageing laboratory inAGE, Universitätsklinik für Neurologie, Inselspital Bern, University of Bern, Bern, 3010, Switzerland. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
White matter hyperintensities (WMHs) are the imaging hallmark of cerebral small vessel disease (SVD), yet their microstructural composition, spatial heterogeneity, and relationship to diffuse normal-appearing white matter (NAWM) damage and cardiovascular risk remain incompletely defined. In 363 community-dwelling adults from the BrainLaus cohort (mean age 55.5 years; range 19.8–89.4; 48.8% male), we combined quantitative relaxometry (MTsat, R1, R2*) and diffusion-derived metrics (FA, MD, NODDI, g-ratio). WMHs were automatically segmented on FLAIR and microstructure was quantified across lobes, white matter compartments, and geodesic layers extending from the WMH core into surrounding NAWM. Multivariate organisation was assessed using principal component analysis, and associations with cardiovascular risk factors were tested using partial least squares. Our analysis revealed demyelination, axonal loss, and extracellular fluid accumulation, particularly in periventricular regions. Layer-specific profiles showed a centrifugal gradient, with myelin loss and oedema at the core and axonal alteration in surrounding tissue. These signatures were associated with age-related cardiovascular risk factors, including higher blood pressure, bioimpedance, and lower haemoglobin levels. WMHs index the endpoint of a broader, spatially structured white matter injury process that extends into NAWM, is regionally concentrated in periventricular tissue, and covaries with systemic vascular/metabolic factors. These findings support sustained vascular risk management to mitigate CSVD-related white matter degeneration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Imaging Neuroscience of Ageing laboratory inAGE, Universitätsklinik für Neurologie, Inselspital Bern, University of Bern, Bern, 3010, Switzerland.
- Laboratory for Research in Neuroimaging LREN, Centre for Research in Neurosciences, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, 1011, Switzerland.
- Signal Processing Laboratory 5, Ecole Polytechnique Fédérale de Lausanne, Lausanne, 1015, Switzerland.
- Graduate School for Health Sciences, University of Bern, Bern, 3012, Switzerland.
- Institute for diagnostic and interventional neuroradiology, Inselspital Bern, University of Bern, Bern, 3012, Switzerland.
ORCID-Profile: Aurélie Bussy, Bogdan Draganski
Zitieren
APA
Bussy, A., Cathala, C., Carneiro, F., Kherif, F., Lutti, A., & Draganski, B. (2026). White matter microstructure fingerprint of cerebral small vessel disease. Brain. https://doi.org/10.1093/brain/awag200
Vancouver
Bussy A, Cathala C, Carneiro F, Kherif F, Lutti A, Draganski B. White matter microstructure fingerprint of cerebral small vessel disease. Brain. 2026. doi:10.1093/brain/awag200
BibTeX
@article{Bussy2026,
author = {Bussy, Aurélie and Cathala, Camille and Carneiro, Fábio and Kherif, Ferath and Lutti, Antoine and Draganski, Bogdan},
title = {White matter microstructure fingerprint of cerebral small vessel disease},
journal = {Brain},
year = {2026},
doi = {10.1093/brain/awag200}
}
EUVIMED